The relationship between the extent of valve damage and pre-existing intracardiac pathology in children with infective endocarditis
DOI:
https://doi.org/10.14739/2310-1210.2025.6.336213Keywords:
congenital heart defects, heart valve, organ sparing treatments, risk factors, infective endocarditis, odds ratioAbstract
Aim. To identify an association between the extent of heart valve damage and pre-existing intracardiac pathology in children with infective endocarditis.
Materials and methods. The study included pediatric patients with a mean age of 8.9 ± 3.3 years (age range: 3.0 to 14.8 years). All participants had a history of infective endocarditis, as defined by the modified Duke criteria, with involvement of the heart’s valvular apparatus. All patients underwent reconstructive heart valve surgeries at the Department of Surgical Treatment of Congenital Heart Defects in Newborns and Young Children at the SI “Amosov National Institute of Cardiovascular Surgery, National Academy of Medical Sciences of Ukraine”. The data for analysis were extracted from primary medical records, including medical history charts, operative protocols, and clinical and instrumental examination data. All patients (or their parents) provided informed voluntary consent.
Results. The paper presents findings on the anatomical features of congenital heart defects that preceded the development of infective endocarditis. Non-cyanotic congenital heart defects were found to be the predominant pre-existing pathology (92.4 %) compared to cyanotic defects (7.6 %). Lesions of the heart’s valvular apparatus were also analyzed, which influenced the type of surgical intervention (organ-sparing vs. prosthetic replacement). Aortic valve lesions were significantly more frequent (29.6 %) than mitral (χ2 = 9.68; p = 0.002) and tricuspid (χ2 = 20.70; p = 0.0001) lesions. An association was found between the extent of heart valve damage and the pre-existing intracardiac pathology.
Conclusions. Organ-sparing operations significantly prevailed in the comparison group. However, in the main group, mitral valve replacement significantly outnumbered organ-sparing procedures (χ2 = 4.55; p = 0.03). The risk of valve replacement in the main group was found to be 2.5 times higher compared to patients without congenital heart defects (OR = 2.50; 95 % CI: 0.64–9.65; p = 0.1).
References
Kovalenko VM, Nesukai OH, Knyshov HV, Vatutin MT, Voronkov LH, Illiash MH, et al. Profilaktyka, diahnostyka ta likuvannia infektsiinoho endokardytu. Rekomendatsii robochoi hrupy z khvorob miokarda, perykarda, endokarda ta klapaniv sertsia Asotsiatsii kardiolohiv Ukrainy [Prevention, diagnosis and treatment of infective endocarditis. Recommendations of the Working Group on Myocardial, Pericardial, Endocardial and Heart Valve Diseases of the Ukrainian Cardiology Association]. Ukrainian Journal of Cardiology. 2015;(6):11-24. Ukrainian. Available from: http://nbuv.gov.ua/UJRN/Ukzh_2015_6_3
Nappi F. Native Infective Endocarditis: A State-of-the-Art-Review. Microorganisms. 2024;12(7):1481. doi: https://doi.org/10.3390/microorganisms12071481
Cahill TJ, Harrison JL, Jewell P, Onakpoya I, Chambers JB, Dayer M, et al. Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis. Heart. 2017;103(12):937-44. doi: https://doi.org/10.1136/heartjnl-2015-309102
Dias M, Amorim R, Correia AL, Pereira M, Correia-Costa A, Reis-Melo A, et al. Hospitalizations for Infective Endocarditis in Children: 15-Year Analysis. Acta Med Port. 2025;38(6-7):377-84. doi: https://doi.org/10.20344/amp.22196
Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40(39):3222-32. doi: https://doi.org/10.1093/eurheartj/ehz620. Erratum in: Eur Heart J. 2020;41(22):2091. doi: https://doi.org/10.1093/eurheartj/ehz803
Amir G, Frenkel G, Rotstein A, Nachum E, Bruckheimer E, Lowenthal A, et al. Urgent Surgical Treatment of Aortic Endocarditis in Infants and Children. Pediatr Cardiol. 2019;40(3):580-4. doi: https://doi.org/10.1007/s00246-018-2030-5
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075-128. doi: https://doi.org/10.1093/eurheartj/ehv319
Ambrosioni J, Hernández-Meneses M, Durante-Mangoni E, Tattevin P, Olaison L, Freiberger T, et al. Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000-2012). Infect Dis Ther. 2023;12(4):1083-101. doi: https://doi.org/10.1007/s40121-023-00763-8. Erratum in: Infect Dis Ther. 2023;12(12):2819-21. doi: https://doi.org/10.1007/s40121-023-00898-8
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739-91. doi: https://doi.org/10.1093/eurheartj/ehx391
Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35-e71. doi: https://doi.org/10.1161/CIR.0000000000000932
Seraj SM, Gill E, Sekhon S. Isolated pulmonary valve endocarditis: truth or myth? J Community Hosp Intern Med Perspect. 2017;7(5):329-31. doi: https://doi.org/10.1080/20009666.2017.1374808
Senko OH. [Features of the Clinical Course of Infective Endocarditis in Children]. Ukrainian Journal of Cardiovascular Surgery. 2025;33(2):41-6. Ukrainian. doi: https://doi.org/10.63181/ujcvs.2025.33(2).41-46
Xiao J, Yin L, Lin Y, Zhang Y, Wu L, Wang Z. A 20-year study on treating childhood infective endocarditis with valve replacement in a single cardiac center in China. J Thorac Dis. 2016;8(7):1618-24. doi: https://doi.org/10.21037/jtd.2016.06.15
Vicent L, Luna R, Martínez-Sellés M. Pediatric Infective Endocarditis: A Literature Review. J Clin Med. 2022;11(11):3217. doi: https://doi.org/10.3390/jcm11113217
Kawamura J, Ueno K, Taimura E, Matsuba T, Imoto Y, Jinguji M, et al. Case Report: 18F-FDG PET-CT for Diagnosing Prosthetic Device-Related Infection in an Infant With CHD. Front Pediatr. 2021;9:584741. doi: https://doi.org/10.3389/fped.2021.584741
Fedchenko M, Giang KW, Snygg-Martin U, Dellborg M, Mandalenakis Z. Risk and predictors of first-time infective endocarditis in adult patients with congenital heart disease-A nationwide, register-based study. Int J Cardiol. 2025;426:133081. doi: https://doi.org/10.1016/j.ijcard.2025.133081
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 O. H. Senko, V. V. Lazoryshynets
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. 
